Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Arqule
Arqule
5 Speculative Biotech Stocks With Catalysts Pending: Revisited
Seeking Alpha
Wed, 07/17/13 - 12:42 pm
NewLink Genetics
OncoSec Medical
Arqule
Raptor Pharmaceuticals
Zogenix
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Mon, 04/1/13 - 10:58 am
ARQ092
Daiichi Sankyo
Arqule
akt protein inhibitor
cancer
ArQule Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thu, 03/14/13 - 10:49 am
earnings
Arqule
ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib
Yahoo/Fly on the Wall
Thu, 01/31/13 - 10:48 am
Arqule
tivantinib
hepatocellular carcinoma
Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
Seeking Alpha
Tue, 01/15/13 - 11:39 am
tivantinib
Arqule
colorectal cancer
Daiichi Sankyo
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 01/12/13 - 10:38 am
Arqule
Sequenom
Idenix
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
ArQule: An Inexpensive And Well-Financed Oncology Opportunity
Seeking Alpha
Thu, 12/13/12 - 04:29 pm
Arqule
Daiichi Sankyo
ARQ-087
3 Biotechs With Good FDA News
Motley Fool
Wed, 10/17/12 - 11:49 am
FDA
Arqule
Threshold Pharmaceuticals
Amarin
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
Seeking Alpha
Fri, 10/12/12 - 12:17 pm
Arqule
tivantinib
Exelixis
cabozantinib
non-small cell lung cancer
Weekend Recap: Biotech Madness
Seeking Alpha
Sun, 10/7/12 - 11:47 am
Sarepta Therapeutics
Synta Pharmaceuticals
Arena Pharmaceuticals
Arqule
Amarin
Acadia
Aeterna Zentaris
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tue, 10/2/12 - 11:25 am
Arqule
lung cancer
Daiichi Sankyo
tivantinib
non-small cell lung cancer
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
Fri, 08/31/12 - 12:27 pm
tivantinib
Arqule
lung cancer
Tarceva
Roche
Astellas
ArQule Shares Drop on Lung Cancer Drug Safety Concern
Minyanville
Wed, 08/29/12 - 12:17 pm
Arqule
lung cancer
tivantinib
3 Innovative Biotech Stocks To Consider Today
Seeking Alpha
Mon, 08/13/12 - 01:36 pm
Celgene
OncoSec
Onyx
Bayer
Arqule
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
ASCO
Synta
Sunesis
Arqule
Cyclacel
Aveo
Bristol-Myers Squibb
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Ziopharm
Zalicus
EXACT Sciences
Geron
Lexicon Pharmaceuticals
Nektar
Vical
Celgene
Celsion
ChemoCentryx
Clovis Oncology
Eli Lilly
JNJ
Pfizer
Elan
Biomarin
Biogen Idec
Auxilium
Arqule
Anthera
Acadia
Amicus Therapeutics
Vertex Pharmaceuticals
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thu, 05/17/12 - 10:35 am
ASCO
Array Biopharma
Exelixis
Pharmacyclics
Onyx
Seattle Genetics
Aveo
Ariad Pharmaceuticals
Arqule
Oncothyreon
Upcoming ASCO Meeting Could Move These Stocks
Seeking Alpha
Wed, 04/4/12 - 08:45 am
ASCO
Allos
Ariad Pharmaceuticals
Arqule
Array Biopharma
ImmunoCellular Therapeutics
Exelixis
Pages
« first
‹ previous
1
2
3
next ›
last »